Canada Life’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Canada Life’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-360	Closed	-$12K	–	2604
2014 Q4	$12K	Hold	360	–	–	﹤0.01%	2404
2014 Q3	$13K	Hold	360	–	–	﹤0.01%	2372
2014 Q2	$12K	Hold	360	–	–	﹤0.01%	2302
2014 Q1	$14K	Buy	+360	New	+$13.2K	﹤0.01%	2180

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Canada Life's WX Position: Q1 2015 in Review

Canada Life sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 360 shares — an estimated $12K sold.

Canada Life first reported a position in WX in Q1 2014 and held it in 4 quarters. The position peaked at $14K in Q1 2014. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

Canada Life reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
Canada Life sold 360 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $12K.
Canada Life first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 4 quarters.
Canada Life's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $14K in Q1 2014.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Canada Life's 13F filing for Q1 2015, filed 6 May 2015.